| ²é¿´: 3864 | »Ø¸´: 5 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
ashlinkÌú¸Ëľ³æ (ÎÄ̳¾«Ó¢)
|
[½»Á÷]
»áÒéÂÛÎÄÕªÒªºÍÕªÒªºÏ¼¯ÖÐÒ»²¿·ÖµÄÎÄÏ×Ó¦µ±ÈçºÎ²éѯ
|
|||
|
ÈçÌâ¡£Çó´óÉñ°ï棡 ÉùÃ÷£º²»ÊÇÒªÒÔÏÂÎÄÏ×µÄÈ«ÎÄ£¬¶øÊÇÒª²éѯÒÔÏÂÎÄÏ׵ķ½·¨£¬Ð»Ð»£¡ ![]() »áÒéÂÛÎÄժҪʾÀý£º Round E, Shentu Y, Golm GT, et al. Safety and efficacy of sitagliptin added to the combination of sulfonylurea and metformin in patients with type 2 diabetes mellitus and inadequate glycemic control [abstract]. 73rd Annual Meeting of the American Diabetes Association; 21¨C25 June. 2013; Chicago (IL) ÕªÒªºÏ¼¯ÖеÄÎÄÏ×ʾÀý£º 1¡¢Kaltenboeck A, Ivanova J, Thomas N, et al. Health care resource use and costs in patients with type 2 diabetes mellitus after treatment initiation with saxagliptin or sitagliptin [abstract no. PDB31]. Value Health. 2013;16(3):A161. 2¡¢ Hutchings A, Tolley K, Achana F, et al. Cost-effectiveness of saxagliptin compared to sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) [abstract no. PDB39]. Value Health. 2011;14(7):A478 Èç¹ûÓиüºÃµÄ¼ìË÷·½·¨£¬Çë¼ÌÐø»ØÌû£¬Â¥Ö÷»áÊÓÇé¿öÔö¼ÓÐüÉÍ¡£Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
±¾¿Æ211£¬±¨¿¼085601-310·Ö
ÒѾÓÐ14È˻ظ´
RY£ºÖйú²ú³öµÄ¿ÆÑ§À¬»øÂÛÎÄ£¬¾ø¶ÔÊýÁ¿ºÍ±ÈÀý¶¼ÊÀ½çµÚÒ»
ÒѾÓÐ16È˻ظ´
297£¬¹¤¿Æµ÷¼Á?ºÓÄÏũҵ´óѧ±¾¿Æ
ÒѾÓÐ7È˻ظ´
ҩѧÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
ʳƷÓëÓªÑø£¨0955£©271Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
366Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
085408¹âµçÐÅÏ¢¹¤³Ìר˶355Ò»Ö¾Ô¸³¤´º¹â»úËùµ÷¼Á
ÒѾÓÐ13È˻ظ´
һ־Ը³¶«´óѧ071000ÉúÎïѧѧ˶³õÊÔ·ÖÊý276Çóµ÷¼Á
ÒѾÓÐ25È˻ظ´
ҩѧ305Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
ת³¤Æ¸ÁË
ÒѾÓÐ6È˻ظ´

sunshan4379
°æÖ÷ (ÎÄ̳¾«Ó¢)
- LS-EPI: 131
- Ó¦Öú: 218 (´óѧÉú)
- ¹ó±ö: 7.08
- ½ð±Ò: 129140
- É¢½ð: 57852
- ºì»¨: 419
- ɳ·¢: 1036
- Ìû×Ó: 17124
- ÔÚÏß: 4575.2Сʱ
- ³æºÅ: 2420830
- ×¢²á: 2013-04-16
- ÐÔ±ð: GG
- רҵ: Â߼ѧ
- ¹ÜϽ: ¼ìË÷֪ʶ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
ashlink: ½ð±Ò+10, ллÌṩºÃ·½·¨£¡Ö®Ç°Ò»Ö±ÔÚpubmedÕÒ£¬Ã»ÕÒµ½¡¡ 2015-01-25 18:00:52
ashlink: ½ð±Ò+10, ллÌṩºÃ·½·¨£¡Ö®Ç°Ò»Ö±ÔÚpubmedÕÒ£¬Ã»ÕÒµ½¡¡ 2015-01-25 18:00:52

6Â¥2015-01-25 11:20:46
tangcwk
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
-

ר¼Ò¾Ñé: +373 - LS-EPI: 85
- Ó¦Öú: 236 (´óѧÉú)
- ¹ó±ö: 13.252
- ½ð±Ò: 323027
- É¢½ð: 23008
- ºì»¨: 947
- ɳ·¢: 696
- Ìû×Ó: 40897
- ÔÚÏß: 4614.3Сʱ
- ³æºÅ: 3046946
- ×¢²á: 2014-03-13
- רҵ: ¸ß·Ö×Ó¿ÆÑ§
- ¹ÜϽ: ÎÄÏ×ÇóÖú

2Â¥2015-01-24 20:49:23
ashlink
Ìú¸Ëľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 32 (СѧÉú)
- ½ð±Ò: 4464.3
- É¢½ð: 3797
- ºì»¨: 25
- ɳ·¢: 101
- Ìû×Ó: 11196
- ÔÚÏß: 819.5Сʱ
- ³æºÅ: 3444640
- ×¢²á: 2014-09-27
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ

3Â¥2015-01-25 07:08:08
tangcwk
ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)
-

ר¼Ò¾Ñé: +373 - LS-EPI: 85
- Ó¦Öú: 236 (´óѧÉú)
- ¹ó±ö: 13.252
- ½ð±Ò: 323027
- É¢½ð: 23008
- ºì»¨: 947
- ɳ·¢: 696
- Ìû×Ó: 40897
- ÔÚÏß: 4614.3Сʱ
- ³æºÅ: 3046946
- ×¢²á: 2014-03-13
- רҵ: ¸ß·Ö×Ó¿ÆÑ§
- ¹ÜϽ: ÎÄÏ×ÇóÖú
¡ï ¡ï
ashlink: ½ð±Ò+2, лл°ïÖú 2015-01-26 14:33:27
ashlink: ½ð±Ò+2, лл°ïÖú 2015-01-26 14:33:27
|
ÄÜÕÒµ½µÄ£¬²»¹ýÎÒÏÖÔÚצ»ú²»·½±ã½ØÍ¼²éÕÒ¡£ ÕÒ²»µ½ÊÇÄã²»¹»Å¬Á¦☺ °´ÕÕA478¾ÍÄÜÕÒµ½£¬Ó¦¸ÃÊǺöàÕªÒªÔÚͬһ¸öPDFÀïÃæ [ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ] |

4Â¥2015-01-25 07:32:19















»Ø¸´´ËÂ¥